Foundation Medicine
Cancer patients seeking targeted therapy options
Prices verified Aug 13, 2026 on Foundation Medicine's own site
Test Performance
Sensitivity
N/A
Specificity
N/A
Detection Method
Genomic profiling
Turnaround
6-7 days median
Key Features
324-gene genomic panel • 324 genes • FDA-approved companion diagnostic • Treatment matching
Who It's For
Suited to: Cancer patients seeking targeted therapy options
Not suited to: Initial cancer screening
This test is ordered by an oncologist after a cancer diagnosis. It is not a screening test for people without cancer. See the screening tests.
Important Notes
Not for screening - analyzes existing tumors. Industry standard for tumor genomic profiling (324 genes). FoundationOne CDx (tissue, 7-day median) and FoundationOne Liquid CDx (blood, 6-day median) are both FDA approved. Broader portfolio includes FoundationOne Heme, RNA, Germline and PGx.
Learn more about Foundation Medicine
Discuss with your physician before ordering.
Visit Foundation MedicineCompare All